Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 08, 2013 08:30 ET | Source: Plandai Biotechnology, Inc.

Plandai Biotechnology, Inc. Molecularly Changing the Botanical Extract Industry

NEW YORK, NY--(Marketwired - May 8, 2013) - That loud noise coming from the botanical extract industry is Plandaí Biotechnology, Inc. (OTCQB: PLPL) landing on the scene with three highly...
May 01, 2013 08:30 ET | Source: Plandai Biotechnology, Inc.

Stock House Group Report Initiates Coverage on Plandai Biotechnology, Inc.

NEW YORK, NY--(Marketwired - May 1, 2013) - After careful analysis, Stock House Group, a full service research and content development investor relations firm, has initiated coverage and placed a...
April 16, 2013 08:30 ET | Source: Nuvilex, Inc.

Human Clinical Trials Using Medical Marijuana Could Be Close in the U.S.

NEW YORK, NY--(Marketwired - Apr 16, 2013) - With more and more acceptance of medical marijuana here in the U.S., companies like Nuvilex, Inc. (OTCQB: NVLX), and research centers like the...
April 10, 2013 08:30 ET | Source: Nuvilex, Inc.

Nuvilex, Inc. Can Benefit From Passage of This Week's Medical Marijuana Bill

NEW YORK, NY--(Marketwired - Apr 10, 2013) - Nuvilex, Inc. (OTCQB: NVLX) and its subsidiary Medical Marijuana Sciences, Inc. received some good news this week as Maryland lawmakers passed a bill...
April 08, 2013 08:30 ET | Source: Nuvilex, Inc.

Nuvilex, Inc. Expects its Technology Can Start to Change Life for Diabetics

NEW YORK, NY--(Marketwired - Apr 8, 2013) - When Nuvilex, Inc. (OTCQB: NVLX) started its diabetes studies, it was likely well known then that while its late-stage pancreatic cancer trials are front...
April 01, 2013 08:30 ET | Source: Nuvilex, Inc.

Nuvilex, Inc. Phase III Clinical Trials in Strong Hands With Dr. Gerald Crabtree

NEW YORK, NY--(Marketwire - Apr 1, 2013) - Nuvilex, Inc. (OTCQB: NVLX) CEO, Dr. Robert Ryan knew exactly what he was doing two years ago when he announced Dr. Gerald Crabtree would be joining his...
March 18, 2013 08:30 ET | Source: Nuvilex, Inc.

Nuvilex, Inc. Diabetes Studies Could Eliminate Need for Daily Insulin Requirements

NEW YORK, NY--(Marketwire - Mar 18, 2013) - When investors look into biotechnology and pharmaceutical companies as an investment opportunity, three areas of research stand out as the most favorable...